Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14069734 | 0.96 | SIGMAR1 (0.38) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL13304810 | 0.90 | SIGMAR1 (0.39) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL12442846 | 0.89 | CYP2A6 (0.36) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL13250576 | 0.88 | SIGMAR1 (0.42) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL13767879 | 0.88 | SIGMAR1 (0.39) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL14867151 | 0.87 | SIGMAR1 (0.40) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL17468436 | 0.87 | SIGMAR1 (0.43) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL2332208 | 0.87 | SIGMAR1 (0.43) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL2325158 | 0.86 | SIGMAR1 (0.39) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 | |
| SCHEMBL24702723 | 0.85 | SIGMAR1 (0.42) | ALDH1A1HSD17B10HIF1ACYP1B1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1775335-A2 | Organic lectroluminescent element | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2007-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ALDH1A1 2388/4885HSD17B10 2146/4885HIF1A 3576/4885 |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ALDH1A1 2388/4885HSD17B10 2146/4885HIF1A 3576/4885 |
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | ARL1, RIF1, EML4 | ALDH1A1 699/4885HSD17B10 3421/4885HIF1A 3654/4885 |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ALDH1A1 2388/4885HSD17B10 2146/4885HIF1A 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.